<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>医药魔方 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2021-01-11T12:00:57+08:00</updated>
  <subtitle>世事洞明皆学问，人情练达即文章</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>维昇药业宣布完成1.5亿美元B轮融资，加速大中华区创新内分泌疗法研发</title>
    <updated>2021-01-11T07:45:32+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-11:/s/PGj52rppZI0J-hfd9zFAKQ</id>
    <link href="https://mp.weixin.qq.com/s/PGj52rppZI0J-hfd9zFAKQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>亿腾景昂药业和Aadi Bioscience就ABI-009（西罗莫司白蛋白结合型纳米颗粒）达成大中华区独家授权合作</title>
    <updated>2021-01-11T07:45:32+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-11:/s/LLyjH9HLdohUOxufRw6AUA</id>
    <link href="https://mp.weixin.qq.com/s/LLyjH9HLdohUOxufRw6AUA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>领袖汇聚倒计时丨中国肿瘤医药营销趋势论坛—医学分论坛</title>
    <updated>2021-01-11T07:45:32+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-11:/s/VARvnnnzNpFucBDn2VENCA</id>
    <link href="https://mp.weixin.qq.com/s/VARvnnnzNpFucBDn2VENCA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>巡礼2021｜从战略到执行，打造BD王者</title>
    <updated>2021-01-11T07:45:32+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-11:/s/pVkUJvO_k2uLTX_-zpBtbQ</id>
    <link href="https://mp.weixin.qq.com/s/pVkUJvO_k2uLTX_-zpBtbQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>再鼎医药1.75亿美元引进重症肌无力新药！加码布局自身免疫疾病业务</title>
    <updated>2021-01-10T12:57:46+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-10:/s/kE7G6TaSRiKVtw8W0cqJ9Q</id>
    <link href="https://mp.weixin.qq.com/s/kE7G6TaSRiKVtw8W0cqJ9Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>亘喜生物纳斯达克IPO上市</title>
    <updated>2021-01-10T12:57:46+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-10:/s/NIRCRAUD7ZcNsZOQOnMZ5w</id>
    <link href="https://mp.weixin.qq.com/s/NIRCRAUD7ZcNsZOQOnMZ5w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>男女均有效！开拓药业普克鲁胺阻止新冠患者轻症向重症转化，效果显著</title>
    <updated>2021-01-10T12:57:46+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-10:/s/GfcsVrVCM_-mOMmANa9eCA</id>
    <link href="https://mp.weixin.qq.com/s/GfcsVrVCM_-mOMmANa9eCA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>江湖你我——2020年国内CRO行业回顾</title>
    <updated>2021-01-09T10:29:12+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-09:/s/EU7bDGdjlMEXC1b72iLSrg</id>
    <link href="https://mp.weixin.qq.com/s/EU7bDGdjlMEXC1b72iLSrg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【最新综述】胰腺癌免疫疗法的机遇与挑战</title>
    <updated>2021-01-08T07:54:23+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-08:/s/J54NfmLWqdRIsFTK9UFRjA</id>
    <link href="https://mp.weixin.qq.com/s/J54NfmLWqdRIsFTK9UFRjA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>维昇药业TransCon C-型利钠肽II期中国临床试验申请获批</title>
    <updated>2021-01-08T07:54:23+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-08:/s/oQIsHk6acYRm0YpPYoufsA</id>
    <link href="https://mp.weixin.qq.com/s/oQIsHk6acYRm0YpPYoufsA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>贝达药业万江：成功的肿瘤药营销重在患者可及，最终塑成品牌、商业双赢</title>
    <updated>2021-01-08T07:54:23+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-08:/s/4LHn7t31nMlLBMRrwMq3YQ</id>
    <link href="https://mp.weixin.qq.com/s/4LHn7t31nMlLBMRrwMq3YQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>一图读懂 | 2020年乳腺癌指南更新，NCCN vs CSCO对比</title>
    <updated>2021-01-08T07:54:23+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-08:/s/StpAxhKz6TYrZoC2X8gPQw</id>
    <link href="https://mp.weixin.qq.com/s/StpAxhKz6TYrZoC2X8gPQw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020年创新药获批最大赢家：诺华</title>
    <updated>2021-01-07T08:08:10+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-07:/s/hNNIFrWj2Pz__Qrs__1IRA</id>
    <link href="https://mp.weixin.qq.com/s/hNNIFrWj2Pz__Qrs__1IRA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>降糖药市场TOP10中国公司产品管线对比</title>
    <updated>2021-01-07T08:08:10+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-07:/s/qXEDQO3JDxOcS5xCYX4XiQ</id>
    <link href="https://mp.weixin.qq.com/s/qXEDQO3JDxOcS5xCYX4XiQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>武田副总裁陈杰博士：洞见悬而未决的中国特色临床痛点</title>
    <updated>2021-01-07T08:08:10+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-07:/s/BaXPsXsDvFj-iMO09AAsjA</id>
    <link href="https://mp.weixin.qq.com/s/BaXPsXsDvFj-iMO09AAsjA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>注册管理丨给热爱以岁月，给努力以路径</title>
    <updated>2021-01-07T08:08:10+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-07:/s/Xa-H6IOr2qtVMgtRaMa7qQ</id>
    <link href="https://mp.weixin.qq.com/s/Xa-H6IOr2qtVMgtRaMa7qQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>礼来乳腺癌新药唯择®（阿贝西利片）在华获批！</title>
    <updated>2021-01-06T08:11:10+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-06:/s/yw5aa6xHxVXHu-MFJ0rtFQ</id>
    <link href="https://mp.weixin.qq.com/s/yw5aa6xHxVXHu-MFJ0rtFQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>艾棣维欣向INOVIO提供DNA疫苗生产技术许可，共同推进新冠疫苗II/III期临床及商业化</title>
    <updated>2021-01-06T08:11:10+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-06:/s/gFujT-ObDZ2vNwaITCL2kw</id>
    <link href="https://mp.weixin.qq.com/s/gFujT-ObDZ2vNwaITCL2kw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>专注高技术壁垒复杂制剂！燃点医药获得数千万元天使轮融资</title>
    <updated>2021-01-06T08:11:10+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-06:/s/eilGOZiFDKaVOQOlke3Gmw</id>
    <link href="https://mp.weixin.qq.com/s/eilGOZiFDKaVOQOlke3Gmw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>维健医药与Immedica签署协议，维健医药获得Ravicti®在中国和其他若干亚太国家的独家商业化权益</title>
    <updated>2021-01-06T08:11:10+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-06:/s/AHwHEIUOQux7J4qbXsgKUw</id>
    <link href="https://mp.weixin.qq.com/s/AHwHEIUOQux7J4qbXsgKUw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>